uniQure N.V. (QURE)
NASDAQ: QURE · Real-Time Price · USD
5.78
-0.07 (-1.11%)
Nov 22, 2024, 4:00 PM EST - Market closed
uniQure Market Cap
uniQure has a market cap or net worth of $281.74 million as of November 22, 2024. Its market cap has decreased by -14.42% in one year.
Market Cap
281.74M
Enterprise Value
343.21M
1-Year Change
-14.42%
Ranking
Category
Stock Price
$5.78
Market Cap Chart
Since March 15, 2017, uniQure's market cap has increased from $161.10M to $281.74M, an increase of 74.88%. That is a compound annual growth rate of 7.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 277.80M | -14.18% |
| Dec 29, 2023 | 323.70M | -69.50% |
| Dec 30, 2022 | 1.06B | 10.73% |
| Dec 31, 2021 | 958.50M | -40.38% |
| Dec 31, 2020 | 1.61B | -48.57% |
| Dec 31, 2019 | 3.13B | 190.93% |
| Dec 31, 2018 | 1.07B | 78.06% |
| Dec 29, 2017 | 603.40M | 274.55% |
| Mar 15, 2017 | 161.10M | - |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aldeyra Therapeutics | 289.41M |
| Eton Pharmaceuticals | 288.98M |
| Immutep | 288.89M |
| Rezolute | 287.69M |
| Atea Pharmaceuticals | 283.37M |
| AngioDynamics | 278.35M |
| NeuroPace | 278.18M |
| Tevogen Bio Holdings | 274.78M |